medinfoАктуальные проблемы теоретической и клинической медициныActual Problems of Theoretical and Clinical Medicine2790-12892790-1297Казахстанско-Российский медицинский университетmedinfo-130Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL ARTICLESНЕОБХОДИМА ЛИ ТЕХНОЛОГИЯ С ИСПОЛЬЗОВАНИЕМ ПЛАЗМЫ, ОБОГАЩЕННОЙ ТРОМБОЦИТАМИ И ЛЕЙКОЦИТАМИIS THE TECHNOLOGY USING PLASMA ENRICHED WITH PLATELETS AND WHITE BLOOD CELLS NECESSARYФазыловТ. Р.FazylovT. R.ДуйсеновН. Б.DuisenovN. B.

д.м.н.

MD

НУО «Казахстанско-Российский медицинский университет»КазахстанNEI «Kazakh-Russian Medical University»Kazakhstan202001112022035355Copyright © Фазылов Т.Р., Дуйсенов Н.Б., 20222022Фазылов Т.Р., Дуйсенов Н.Б.Fazylov T.R., Duisenov N.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://kazrosmedjournal.krmu.edu.kz/jour/article/view/130

Введение. Терапия обогащенной тромбоцитами и лейкоцитами плазмой (PRP) - это современный метод, который использует аутологичную плазму для улучшения и ускорения за живления костей.Цель. Для определения уровня безопасности и эффективности методики используют плазму, обогащенную тромбоцитами и лейкоцитами.Материалы и методы. Поиск проводился с использованием баз данных PubMed, Cochrane и Web of Science. Поиск осуществлялся по ключевым словам без языковых ограничений .Актуальность. Терапия костных дефектов является серьезной проблемой для врача-травматолога. Костные дефекты часто развиваются при тяжелой травме или в результате больших объемных резекций в результате таких патологий, как опухоли или костная инфекция.Вывод. Несмотря на существующие преимущества, использование технологии PRP не является полностью оправданным. Необходимо провести еще много качественных клинических испытаний, которые окончательно поставят крест на эффективности метода.

Background. Platelet and white blood cell rich plasma (PLRP) therapy is a newly developed method that uses autologous plasma to improve and accelerate bone healing.Purpose. To determine the level of safety and effectiveness of the technique using plasma enriched with platelets and white blood cells.Materials and methods. A search was performed using PUBMED, Cochrane, and web of Science databases. The search was performed using keywords with no language restrictions.Relevance. Therapy in bone defects is a serious challenge for a trauma Clinician. Bone defects often develop with severe trauma or as a result of large volume resections as a result of pathologies such as tumors or bone infection.Conclusion. Despite the existing advantages, the use of PLRP technology is not fully justified. It is necessary to perform many more high-quality clinical trials that will finally put an end to the effectiveness of the method.

обогащенная тромбоцитами плазмакостный трансплантатвосстановление костейграфтыplatelet-rich plasmabone graftbone repairReferencesBerner A. [и др.]. Biomimetic tubular nanofiber mesh and platelet rich plasma-mediated delivery of BMP- 7 for large bone defect regeneration // Cell and Tissue Research. 2012.Berner A. [и др.]. Biomimetic tubular nanofiber mesh and platelet rich plasma-mediated delivery of BMP- 7 for large bone defect regeneration // Cell and Tissue Research. 2012.Bowen-Pope D.F., Raines E.W. History of discovery: Platelet-derived growth factor // Arteriosclerosis, Thrombosis and Vascular Biology. 2011.Bowen-Pope D.F., Raines E.W. History of discovery: Platelet-derived growth factor // Arteriosclerosis, Thrombosis and Vascular Biology. 2011.Cachaço A.S. [и др.]. TNF-α regulates the effects of irradiation in the mouse bone marrow microenvironment // PLoS ONE. 2010.Cachaço A.S. [и др.]. TNF-α regulates the effects of irradiation in the mouse bone marrow microenvironment // PLoS ONE. 2010.Calori G.M. [и др.]. The use of bone-graft substitutes in large bone defects: Any specific needs? // Injury. 2011.Calori G.M. [и др.]. The use of bone-graft substitutes in large bone defects: Any specific needs? // Injury. 2011.Dolder J. Van Den [и др.]. Platelet-rich plasma: Quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells // Tissue Engineering. 2006.Dolder J. Van Den [и др.]. Platelet-rich plasma: Quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells // Tissue Engineering. 2006.Frank C., Mcdonald D., Shrive N. Collagen fibril diameters in the rabbit medial collateral ligament scar: A longer term assessment // Connective Tissue Research. 1997.Frank C., Mcdonald D., Shrive N. Collagen fibril diameters in the rabbit medial collateral ligament scar: A longer term assessment // Connective Tissue Research. 1997.Hakimi M. [и др.]. Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs // Injury. 2010.Hakimi M. [и др.]. Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs // Injury. 2010.Han B. [и др.]. The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteoinductivity // Journal of Bone and Joint Surgery - Series A. 2009.Han B. [и др.]. The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteoinductivity // Journal of Bone and Joint Surgery - Series A. 2009.Kanthan S.R. [и др.]. Platelet-rich plasma (PRP) enhances bone healing in non-united critical-sized defects: A preliminary study involving rabbit models // Injury. 2011.Kanthan S.R. [и др.]. Platelet-rich plasma (PRP) enhances bone healing in non-united critical-sized defects: A preliminary study involving rabbit models // Injury. 2011.Kim E.S., Kim J.J., Park E.J. Angiogenic factorenriched platelet-rich plasma enhances in vivo bone formation around alloplastic graft material // Journal of Advanced Prosthodontics. 2010.Kim E.S., Kim J.J., Park E.J. Angiogenic factorenriched platelet-rich plasma enhances in vivo bone formation around alloplastic graft material // Journal of Advanced Prosthodontics. 2010.Lyras D.N. [и др.]. The effect of platelet-rich plasma gel in the early phase of patellar tendon healing // Archives of Orthopaedic and Trauma Surgery. 2009.Lyras D.N. [и др.]. The effect of platelet-rich plasma gel in the early phase of patellar tendon healing // Archives of Orthopaedic and Trauma Surgery. 2009.Mannaioni P.F., Bello M.G. Di, Masini E. Platelets and inflammation: Role of platelet-derived growth factor, adhesion molecules and histamine // Inflammation Research. 1997.Mannaioni P.F., Bello M.G. Di, Masini E. Platelets and inflammation: Role of platelet-derived growth factor, adhesion molecules and histamine // Inflammation Research. 1997.Olofsson B. [и др.]. Vascular endothelial growth factor B, a novel growth factor for endothelial cells // Proceedings of the National Academy of Sciences of the United States of America. 1996.Olofsson B. [и др.]. Vascular endothelial growth factor B, a novel growth factor for endothelial cells // Proceedings of the National Academy of Sciences of the United States of America. 1996.Oryan A. [и др.]. Effects of combined hydroxyapatite and human platelet rich plasma on bone healing in rabbit model: Radiological, macroscopical, hidtopathological and biomechanical evaluation // Cell and Tissue Banking. 2012.Oryan A. [и др.]. Effects of combined hydroxyapatite and human platelet rich plasma on bone healing in rabbit model: Radiological, macroscopical, hidtopathological and biomechanical evaluation // Cell and Tissue Banking. 2012.Pieske O. [и др.]. Autologous bone graft versus demineralized bone matrix in internal fixation of ununited long bones // Journal of Trauma Management & Outcomes. 2009.Pieske O. [и др.]. Autologous bone graft versus demineralized bone matrix in internal fixation of ununited long bones // Journal of Trauma Management & Outcomes. 2009.Pietrzak W.S., Eppley B.L. Platelet rich plasma: Biology and new technology // Journal of Craniofacial Surgery. 2005.Pietrzak W.S., Eppley B.L. Platelet rich plasma: Biology and new technology // Journal of Craniofacial Surgery. 2005.Pintucci G. [и др.]. Trophic effects of platelets on cultured endothelial cells are mediated by plateletassociated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF) // Thrombosis and Haemostasis. 2002.Pintucci G. [и др.]. Trophic effects of platelets on cultured endothelial cells are mediated by plateletassociated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF) // Thrombosis and Haemostasis. 2002.

The authors declare that there are no conflicts of interest present.